Eyenovia

$3.50
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

+$0.05 (+1.47%) Today
+$0.05 (+1.45%) As of 8:00 PM EST after-hours

Why Robinhood?

You can buy or sell Eyenovia and other stocks, options, and ETFs commission-free!

About EYEN

Eyenovia, Inc. Common Stock, also called Eyenovia, is a clinical stage biopharmaceutical company, which engages in the research and development of ophthalmology products. The company offers a piezo-print technology to deliver micro-doses of micro-therapeutics for the eyes. Its products include MicroProst, MicroStat, MicroTears, and MicroPine. The firm is currently focused on the late-stage development of microdosed medications for presbyopia, myopia progression and mydriasis. The company was founded by Sean Ianchulev on March 12, 2014 and is headquartered in New York, NY. The listed name for EYEN is Eyenovia, Inc. Common Stock.

CEO
Sean Ianchulev
Employees
27
Headquarters
New York, New York
Founded
2014
Market Cap
85.85M
Price-Earnings Ratio
Dividend Yield
Average Volume
126.57K
High Today
$3.58
Low Today
$3.34
Open Price
$3.43
Volume
245.35K
52 Week High
$6.92
52 Week Low
$1.11

Collections

EYEN Earnings

-$0.51
-$0.34
-$0.17
$0.00
Q1 FY19
Q2 FY19
Q3 FY19
Q4 FY19
Q1 FY20
Q2 FY20
Q3 FY20
Q4 FY20
Estimated
per share
Actual
Expected Mar 24, After Hours

You May Also Like